MedTrace Logo

The Effect of Attention Training on Symptoms and Emotion Regulation in Depressive Patients

NCT05269433 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-06-03

No results posted yet for this study

Summary

Attention control for external information and cognitive control for internal information play a causal role in emotion regulation according to different theories and research. Prior research shows that an interactive attention control training in which participants learn to unravel scrambled sentences ("life is my a party mess") in a positive manner ("my life is a party") by receiving feedback on their eye movements while attending to the valenced words, can facilitate participants to be more able to re-interpret negative information in a positive manner. In the current study we want to test the effect of psycho-education in combination with a 10 day attention control training to see if this has a positive effect on depressive, anxiety and stress symptoms, emotion regulation and self-esteem in depressed patients. The study takes place in a psychiatric hospital (Alexianen Zorggroep Tienen) while participants are staying there to receive treatment.

Conditions

Interventions

BEHAVIORAL

OCAT-sham

Placebo version of the online contingent attention training preceded by a psycho-education movieclip.

BEHAVIORAL

OCAT

Online contingent attention training preceded by a psycho-education movieclip.

OTHER

Psycho-education video

All groups watch a psycho-education video before the start of the 10-day attention training.

OTHER

Motivational video

Participants in the OCAT+ condition watch a short motivational video before each training session.

Sponsors & Collaborators

  • Alexianen Zorggroep Tienen

    collaborator UNKNOWN

  • Universidad Complutense de Madrid

    collaborator OTHER

  • University Ghent

    lead OTHER

Principal Investigators

  • Rudi De Raedt, Professor · University Ghent

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-08
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05269433 on ClinicalTrials.gov